Table 1:
MRI protocols in Cancer and Control Patients
| Scanner Parameter |
Details | Model | TR (ms) |
TE(m s) |
Contrast Agent Type (Count) |
Subseque nt Cancer Count N (%) |
Control Count (%) |
|---|---|---|---|---|---|---|---|
| Manufacturer | GE Healthcare, Little Chalfont, UK | Signa HDx | 4.88–6.76 | 2.27–2.54 | Magnevist (64) | 21 (46) | 43 (49) |
| Signa HDxt | 4.88–6.10 | 2.28–2.74 | Magnevist (26), Multihance (2) | 5 (11) | 23 (26) | ||
| Siemens, Munich, Germany | MAGNETOM TrioTim | 3.54– 4.09 | 1.36–1.58 | Magnevist (14), Multihance (2), Unknown (5) | 8 (17) | 13 (15) | |
| MAGNETOM Avanto | 4.12–4.54 | 1.27–1.51 | Magnevist (14), Multihance (3), Gadavist (1) | 10 (22) | 8 (9) | ||
| MAGNETOM Trio | 3.54 | 1.4 | Unknown(1) | 1 (2) | 0 (0) | ||
| MAGNETOM Espree | 4 | 1.33 | Magnevist (1) | 1 (2) | 0 (0) | ||
| Magnetic Field Strength | 1.5T | MAGNETOM Avanto | 4.12–4.54 | 1.27–1.51 | Magnevist (14), Multihance (3), Gadavist (1) | 10 (22) | 8 (9) |
| Signa HDxt | 4.88–4.98 | 2.28–2.36 | Magnevist (9) | 3 (7) | 6 (7) | ||
| Signa HDx | 4.88–5.08 | 2.27–2.41 | Magnevist (11) | 1 (2) | 10 (11) | ||
| MAGNETOM Espree, | 4 | 1.33 | Magnevist (1) | 1 (2) | 0 (0) | ||
| 3.0T | Signa HDx | 5.11–6.76 | 2.35–2.54 | Magnevist (53) | 20 (43) | 33 (38) | |
| Signa HDxt | 5.07–6.10 | 2.33–2.74 | Magnevist (17), Multihance(2) | 2 (4) | 17 (20) | ||
| MAGNETOM Trio Tim | 3.54– 4.09 | 1.36–1.58 | Magnevist (14), Multihance (2), Unknown (5) | 8 (17) | 13 (15) | ||
| MAGNETOM Trio | 3.54 | 1.4 | Unknown(1) | 1 (2) | 0 (0) |